TELA Bio (TELA) Net Margin Growth (3y) (2021 - 2026)
TELA Bio (TELA) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | 399.00 |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 1,018.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 1,978.00 |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn | 4,057.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,057.00 |
| Dec 31, 2025 | 4,056.00 |
| Sep 30, 2025 | 5,419.00 |
| Jun 30, 2025 | 5,822.00 |
| Mar 31, 2025 | 7,495.00 |
| Dec 31, 2024 | 26,787.00 |
| Sep 30, 2024 | 9,314.00 |
| Jun 30, 2024 | 11,634.00 |
| Mar 31, 2024 | 12,393.00 |
| Dec 31, 2023 | 6,097.00 |
| Sep 30, 2023 | 6,848.00 |
| Jun 30, 2023 | 8,811.00 |
| Mar 31, 2023 | 8,881.00 |
| Dec 31, 2022 | 7,042.00 |
| Sep 30, 2022 | 7,347.00 |
| Jun 30, 2022 | 13,555.00 |
| Mar 31, 2022 | 10,594.00 |
| Dec 31, 2021 | 28,376.00 |
| Sep 30, 2021 | 6,358.00 |